Botswana vs Iraq: Death rate from Alzheimer's
Botswana
5.33 deaths per 100,000 people
in 2021
Iraq
5.55 deaths per 100,000 people
in 2021
Botswana rank
145th
Iraq rank
142nd
Death rate from Alzheimer's over time
- Botswana
- Iraq
How they compare
Iraq currently reports 5.55 deaths per 100,000 people against 5.33 deaths per 100,000 people in Botswana, a difference of 0.22 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Iraq ahead.
Botswana ranks 145th and Iraq ranks 142nd of 194 countries.
Across the 3 decades both report, Botswana averaged higher in 2 and Iraq in 1.
Head to head by decade
| Decade | Botswana | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.67 deaths per 100,000 people | 5.59 deaths per 100,000 people | 0.916 deaths per 100,000 people | Iraq |
| 2010s | 6.07 deaths per 100,000 people | 5.11 deaths per 100,000 people | 0.965 deaths per 100,000 people | Botswana |
| 2020s | 6.12 deaths per 100,000 people | 5.89 deaths per 100,000 people | 0.225 deaths per 100,000 people | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Botswana or Iraq?
- Iraq, at 5.55 deaths per 100,000 people against 5.33 deaths per 100,000 people in Botswana as of 2021.
- What is the difference in death rate from alzheimer's between Botswana and Iraq?
- 0.22 deaths per 100,000 people, with Iraq ahead.
- How many years of comparable data are there for Botswana and Iraq?
- 22 years are reported by both, from 2000 to 2021.
- How do Botswana and Iraq rank globally for death rate from alzheimer's?
- Botswana ranks 145th and Iraq ranks 142nd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.